FDA Action Alert: Argenx, Aldeyra, Intercept and Sarepta
Pictured: FDA sign with blue sky backdrop/Adobe Stock, Grandbrothers The FDA is racing toward four big decisions this week, including one in liver fibrosis due to non-alcoholic steatohepatitis and another that...
Read more








